1-Boc-3-mercapto-azetidine

• CAS: 941585-25-7
• Catalog Number: ACM941585257
• Category: Other Products
• Molecular Weight: 189.2752
• Molecular Formula: C₈H₁₅NO₂S
• Synonyms: 1-Boc-3-Mercapto-azetidine;tert-butyl 3-sulfanylazetidine-1-carboxylate

Custom Q&A

What is the PubChem CID of 1-Boc-3-mercapto-azetidine?

The PubChem CID of 1-Boc-3-mercapto-azetidine is 58513580.

What is the molecular formula of 1-Boc-3-mercapto-azetidine?

The molecular formula of 1-Boc-3-mercapto-azetidine is C8H15NO2S.

What is the molecular weight of 1-Boc-3-mercapto-azetidine?

The molecular weight of 1-Boc-3-mercapto-azetidine is 189.28 g/mol.

What is the IUPAC name of 1-Boc-3-mercapto-azetidine?

The IUPAC name of 1-Boc-3-mercapto-azetidine is tert-butyl 3-sulfanylazetidine-1-carboxylate.

What is the InChI of 1-Boc-3-mercapto-azetidine?

The InChI of 1-Boc-3-mercapto-azetidine is InChI=1S/C8H15NO2S/c1-8(2,3)11-7(10)9-4-6(12)5-9/h6,12H,4-5H2,1-3H3.

What is the InChIKey of 1-Boc-3-mercapto-azetidine?

The InChIKey of 1-Boc-3-mercapto-azetidine is GUZYDTTYVXLGCV-UHFFFAOYSA-N.

What is the CAS number of 1-Boc-3-mercapto-azetidine?

The CAS number of 1-Boc-3-mercapto-azetidine is 941585-25-7.

What is the XLogP3-AA value of 1-Boc-3-mercapto-azetidine?

The XLogP3-AA value of 1-Boc-3-mercapto-azetidine is 1.2.

How many hydrogen bond donor counts does 1-Boc-3-mercapto-azetidine have?

1-Boc-3-mercapto-azetidine has 1 hydrogen bond donor count.

How many hydrogen bond acceptor counts does 1-Boc-3-mercapto-azetidine have?

1-Boc-3-mercapto-azetidine has 3 hydrogen bond acceptor counts.

Synthetic Use

Downstream Synthesis Route 1

• 31716-01-5
• 941585-25-7

• 933474-94-3

Reference: [1]Location in patent: scheme or table
Hirokawa, Yoshimi; Kinoshita, Hironori; Tanaka, Tomoyuki; Nakamura, Takanori; Fujimoto, Koichi; Kashimoto, Shigeki; Kojima, Tsuyoshi; Kato, Shiro
[Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 1, p. 170 - 174]

Downstream Synthesis Route 2

• 886049-95-2
• 941585-25-7

• 1236007-27-4

Reference: [1]Current Patent Assignee: RAQUALIA PHARMA INC. - WO2010/84767, 2010, A1
Location in patent: Page/Page column 64-65

* For details of the synthesis route, please refer to the original source to ensure accuracy.